Skip to main content

Physician Search

 


Displaying 1 - 1 of 1

Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment

Prostate

The purpose of this study is to evaluate the efficacy and safety of [Lu-177]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with androgen receptor axis-targeted therapy (ARAT).
Prostate
III
Schaffer, Kerry
NCT04647526
VICCURO20124